Systems and methods for tissue processing and preparation of cell suspension therefrom
The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or openings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.
1. A device for preparing cells for transplant, the device comprising:
a tissue processing chamber configured to receive a tissue and a chemical reagent, wherein the chemical reagent chemically dissociates the tissue;
a reciprocating-rotating pestle in the tissue processing chamber, wherein the reciprocating-rotating pestle is actuatable to exert a grinding force on the tissue, wherein the force mechanically dissociates the tissue; and
a cell collection chamber configured to collect a cell suspension comprising the chemically and mechanically dissociated tissue from the tissue processing chamber.
2. The device of claim 1 , further comprising a disintegrator separating the tissue processing chamber from the cell collection chamber.
3. The device of claim 2 , wherein the disintegrator comprises a mesh, screen, grid, blade, or any combination thereof.
4. The device of claim 2 , further comprising a filter arranged between the disintegrator and the cell collection chamber.
5. The device of claim 1 , further comprising a cap removably placed on or hinged to the tissue processing chamber.
6. The device of claim 5 , wherein the reciprocating-rotating pestle is connected to the cap.
7. The device of claim 1 , wherein the grinding force exerted by the reciprocating-rotating pestle comprises compression and a rotational force on the tissue.
8. The device of claim 1 , further comprising an applicator in fluid communication with the cell collection chamber and configured to receive the cell suspension.
9. The device of claim 8 , further comprising at least one pump configured to drive the cell suspension from the cell collection chamber to the applicator.
10. The device of claim 8 , further comprising a filter arranged between the cell collection chamber and the applicator.
11. The device of claim 8 , wherein the applicator is capable of dispensing, spraying, or dripping the cell suspension.
12. The device of claim 8 , wherein the applicator comprises a pivoting head.
13. The device of claim 8 , wherein the applicator is removable from fluid communication with the cell collection chamber.
14. The device of claim 1 , further comprising a support in fluid communication with the cell collection chamber and configured to receive the cell suspension, wherein the support comprises a matrix, a scaffold, a dressing, or any combination thereof.
15. The device of claim 1 , further comprising a container comprising the chemical reagent and in fluid communication with the tissue processing chamber.
16. The device of claim 15 , wherein the chemical reagent comprises an enzyme capable of breaking down extracellular matrix in the tissue, and the container comprises a first compartment and a second compartment separated by a breakable seal, the first compartment containing water and the second compartment containing lyophilized enzyme powder, and wherein when the seal is broken the enzyme powder dissolves in the water.
17. The device of claim 16 , wherein the enzyme comprises trypsin, trypsin-EDTA, dispase, collagenase, thermolysin, pronase, hyaluronidase, elastase, papain, pancreatin, or any combination thereof.
18. The device of claim 1 , further comprising a container comprising a buffer solution, wherein the container is in fluid communication with the tissue processing chamber.
19. The device of claim 1 , further comprising a container comprising an exogenous agent, wherein the container is in fluid communication with the tissue processing chamber.
20. The device of claim 19 , wherein the exogenous agent comprises a heat shock protein or a fragment thereof, hyaluronic acid, platelet-enriched plasma, a growth factor, adipose stem cells, or any combination thereof.